Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency
Clinical trial NCT06452316 · RECRUITING
Trial details
- NCT number
- NCT06452316
- Sponsor
- Claris Biotherapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2027-12-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.